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Abstract
Myocardial strain is a convenient parameter to quantify left ventricular (LV) function. Fast strain-encoding (fSENC) ena-
bles the acquisition of cardiovascular magnetic resonance images for strain-measurement within a few heartbeats during 
free-breathing. It is necessary to analyze inter-vendor agreement of techniques to determine strain, such as fSENC, in order 
to compare existing studies and plan multi-center studies. Therefore, the aim of this study was to investigate inter-vendor 
agreement and test-retest reproducibility of fSENC for three major MRI-vendors. fSENC-images were acquired three times 
in the same group of 15 healthy volunteers using 3 Tesla scanners from three different vendors: at the German Heart Insti-
tute Berlin, the Charité University Medicine Berlin-Campus Buch and the Theresien-Hospital Mannheim. Volunteers were 
scanned using the same imaging protocol composed of two fSENC-acquisitions, a 15-min break and another two fSENC-
acquisitions. LV global longitudinal and circumferential strain (GLS, GCS) were analyzed by a trained observer (Myostrain 
5.0, Myocardial Solutions) and for nine volunteers repeatedly by another observer. Inter-vendor agreement was determined 
using Bland-Altman analysis. Test-retest reproducibility and intra- and inter-observer reproducibility were analyzed using 
intraclass correlation coefficient (ICC) and coefficients of variation (CoV). Inter-vendor agreement between all three sites was 
good for GLS and GCS, with biases of 0.01–1.88%. Test-retest reproducibility of scans before and after the break was high, 
shown by ICC- and CoV values of 0.63–0.97 and 3–9% for GLS and 0.69–0.82 and 4–7% for GCS, respectively. Intra- and 
inter-observer reproducibility were excellent for both parameters (ICC of 0.77–0.99, CoV of 2–5%). This trial demonstrates 
good inter-vendor agreement and test–retest reproducibility of GLS and GCS measurements, acquired at three different 
scanners from three different vendors using fSENC. The results indicate that it is necessary to account for a possible bias 
(< 2%) when comparing strain measurements of different scanners. Technical differences between scanners, which impact 
inter-vendor agreement, should be further analyzed and minimized.
DRKS Registration Number: 00013253.
Universal Trial Number (UTN): U1111-1207-5874.
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Introduction
Myocardial strain has proven to be an important param-
eter for further investigation of myocardial performance in 
addition to conventionally used volumetric measures, such 
as ejection fraction (EF) [1–3]. Strain can be determined 
using echocardiography and cardiovascular magnetic reso-
nance (CMR) imaging. A common technique to measure 
strain in echocardiography is using speckle tracking (STE). 
STE is routinely used, for example to identify systolic dys-
function in heart failure patients with preserved EF [4] 
or as a marker for cardiotoxicity in patients undergoing 
chemotherapy [5]. An important step towards standardiza-
tion of STE in preparation for broad clinical use was the 
recent publication of a consensus document on how strain 
measurements should be performed [6]. However, strain 
is not only influenced by measurement methods, but also 
by image quality, intra- and inter-observer reproducibility, 
the image acquisition system [7] and the post-processing 
software used [8, 9]. As the impact of these various factors 
on strain results remains unclear, guidelines recommend 
STE to be performed using the same vendor’s acquisition 
system and software for individual patients [9].
As CMR emerged as the reference standard of cardiac 
morphology and function [10], various acquisition- and 
post-processing techniques to determine strain using CMR 
have been explored and validated [11]. Long acquisition 
times [12] and long breath-holds in patients with cardiac 
diseases, especially those who suffer from dyspnea, are 
some of the factors currently limiting use in clinical set-
tings. Furthermore, no standardized approach to measure 
strain using CMR has been proposed yet, as was the case 
for STE. The lack of information on the influence of dif-
ferent magnetic resonance scanners and platforms on strain 
results is one challenge preventing standardization of 
CMR techniques. Nevertheless, this information is crucial 
since studies are conducted at different centers with vary-
ing scanners, at different field strengths and using different 
post-processing platforms. Without information on inter-
vendor agreement, CMR-strain should only be determined 
using the same scanner and post-processing software for 
individual patients, as recommended for STE. Although 
this measure reduces possible bias on strain results, no 
comparison can be made between different studies and 
measurements performed at different centers, hampering 
the practicality of using strain routinely and the design of 
multi-center studies to further validate this method.
Strain-encoding (SENC), first described in 2001 by 
Osman et al. [13], is a novel imaging technique to meas-
ure strain. In comparison to myocardial tagging, SENC 
uses tag planes in which the sinusoidal phase is constant 
in parallel to the image plane [13]. Therefore, longitudinal 
strain is determined using short-axis- and circumferential 
strain using long-axis views; radial strain is not measur-
able by SENC. Fast-SENC (fSENC) is a “real-time” scan 
that acquires all necessary data for one slice within one 
single heartbeat [14]. Hence, it is insensitive to breathing 
motion, resulting in a fast magnetic resonance imaging 
(MRI) exam for the patient at free breathing. Studies have 
shown that fSENC is equal or even superior to tagging 
[15] and highly reproducible concerning inter-study, as 
well as intra- and inter-observer reproducibility [2].
The aim of this study was to examine the inter-vendor 
agreement and reproducibility of CMR-derived strain, 
obtained with fSENC in the same group of volunteers at 
three different sites with individual MRI-platforms and 
sequences. In particular, our aims were to
1. investigate inter-vendor agreement of fSENC at 3 T 
using scanners from three major MRI vendors,
2. determine test-retest reproducibility of repeated scans at 
each scanner and
3. determine intra- and inter-observer reproducibility of the 
strain measurements.
Methods
Study population and design
Fifteen healthy volunteers with no history of cardiovascular 
diseases or contraindications against MRI [16] were pro-
spectively identified and recruited for the study after obtain-
ing a written informed consent. The study was approved by 
the Ethics Committee of the Charité-University-Medicine 
in Berlin and complied with the Declaration of Helsinki. 
It was registered at the German Register for Clinical Stud-
ies (DRKS) (registration number: 00013253) and the World 
Health Organization (WHO) (universal trial number (UTN): 
U1111-1207-5874).
Cardiovascular magnetic resonance imaging
CMR images of all fifteen volunteers were acquired repeat-
edly at 3 T on three different scanners (names in alphabetical 
order and not according to site number: Ingenia, Philips, 
Best, The Netherlands; MAGNETOM Verio, Siemens 
Healthcare GmbH, Erlangen, Germany; SIGNA Architect, 
GE Healthcare, Milwaukee, WI, USA). CMR examinations 
took place within five months at: the German Heart Insti-
tute Berlin (site I), the Theresien-Hospital Mannheim (site 
II) and the Max-Delbrück Center for Molecular Medicine 
(MDC) in collaboration with Charité University Medicine 
901The International Journal of Cardiovascular Imaging (2020) 36:899–911 
1 3
Berlin-Campus Buch (site III), each equipped with one of 
the above listed scanners.
Fast strain‑encoding (fSENC)
The techniques applied to the pulse sequence (localized/
reduced field-of-view fSENC, interleaved tuning, spiral 
imaging, ramped flip angle, etc.) to achieve image acquisi-
tion in a single heartbeat have been described previously [2, 
14, 15]. Prior to in-vivo imaging, studies were performed 
in vitro with scanning platforms of the three different ven-
dors using phantoms of very similar proportions, made of 
homogeneous MR-visible silicone gel with known mechanic 
properties [17]. Periodic non-flat compression and expan-
sion was applied using an MR-compatible air cylinder as 
described by Osman et al. [17, 18]. Subsequently, scan-
ning of the fifteen volunteers was performed at all three 
sites. All volunteers were scanned using the same imaging 
protocol, schematically depicted in Fig. 1. Each volunteer 
received four fSENC scans per site, adding up to 60 scans. 
The first two scans were performed consecutively using 
the same scanning parameters. Afterwards the volunteers 
left the scanner room for fifteen minutes, followed by two 
more fSENC acquisitions with the same parameters. Images 
were acquired in three long-axis views (2-chamber (2-ch), 
3-chamber (3-ch), 4-chamber (4-ch)) to calculate left ven-
tricular (LV) global circumferential strain (GCS) and in three 
short-axis views (SAX- basal, mid-ventricular (mid), apical) 
to calculate LV global longitudinal strain (GLS). Scanning 
was performed by the local team of one or two technicians 
at each site after being trained by the same representatives of 
the software provider on performing the fSENC acquisitions 
and completing a written test. Scanning parameters were 
allowed to be adjusted according to the different scanners, if 
needed. Heart rate (bpm) and blood pressure (mmHg) were 
monitored before, during and after the exam. Variables that 
might influence strain measurements, such as height, weight 
and smoking behavior, were determined before the scans at 
every site.
Technical parameters
Site I
At site I, images were acquired using a multi-element 
receive coil array, consisting of an anterior part on the 
patient’s chest and a posterior part embedded in the 
patient table. A flexible number of up to 32 elements 
was employed, where the selection of coil elements was 
performed automatically by the MR software. Image 
acquisition was triggered on the R-wave using a 4-lead 
vector ECG. fSENC imaging parameters at site I were: 
field-of-view = 256 × 256 mm2, slice thickness = 10 mm, 
voxel size = 4 × 4 × 10  mm3, reconstructed images at 
1 × 1 × 10 mm3 using zero-filled interpolation (in-plane 
ZIP 1024), spiral readout (3 interleaves) with acquisi-
tion time (TA) = 10 ms, flip angle = 30°, effective echo 
time (TE) = 0.7 ms, repetition time (TR) = 12 ms, tempo-
ral resolution = 36 ms, typical number of acquired heart 
phases = 22, spectrally selective fat suppression (SPIR), 
total acquisition time per slice < 1 s (1 heartbeat), total 
acquisition time per scan = 6 heartbeats.
Site II
At site II, a user-developed sequence was employed. 
Images were acquired using a multi-element receive 
coil array, as described for site I. fSENC spiral images 
were triggered on the R-wave using a 4-lead vec-
tor ECG. Field-of-view = 256 × 256  mm2, slice thick-
ness = 7-8 mm, voxel size = 4 × 4 × 7 mm3, reconstructed 
images at 1 × 1 × 7  mm3, single-shot spiral readout (4 
interleaves) with acquisition time (TA) = 7.5  ms, flip 
angle = 20°, effective echo time (TE) = 5.0 ms, repeti-
tion time (TR) = 9.1 ms, temporal resolution = 36.4 ms, 
typical number of acquired heart phases = 18, spectrally 
selective fat suppression (SPIR), total acquisition time per 
slice < 1 s (or one heartbeat), total acquisition time per 
scan = 6 heartbeats.
Fig. 1  Schematic outline show-
ing the scan organization with 
a total of four fSENC scans per 
volunteer at every site
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Site III
In comparison to the spiral pulse sequence at sites I and 
II, fSENC at site III is an Echo Planar Imaging (EPI) user-
developed pulse sequence [19]. Volunteers were scanned 
using a 32-channel body coil and image acquisition was 
triggered on the R-wave using a 4-lead vector ECG. Epi-
factor = 9, field-of-view = 450 × 170  mm2, slice thick-
ness = 12 mm, voxel size = 4.7 × 4.7 × 12 mm3, reconstructed 
resolution at 4.7 × 4.7 × 12 mm3, flip angle = 12°, effective 
echo time (TE) = 1.18 ms, repetition time (TR) = 8.9 ms, 
temporal resolution = 35.6 ms, centric EPI recording, typi-
cal number of acquired heart phases = 22, spectrally selec-
tive fat suppression (SPIR). The acquisition happened in a 
single heartbeat, as for sites I and II. A separate heartbeat 
was used for EPI phase correction. The total acquisition time 
per slice was about 2 s (or two heartbeats) and per scan about 
12 heartbeats.
Image analysis
All images were analyzed by one observer (JE) using dedi-
cated software (Myostrain 5.0, Myocardial Solutions, Inc., 
Morrisville, North Carolina, USA), after being trained by 
a representative of the software company and completing 
a written test, as previously described [20]. Figure 2 dem-
onstrates the process of image analysis, starting with the 
acquisition of the image on the scanner (1.), proceeding onto 
the color-coded image on the software, displaying the manu-
ally drawn endo- and epicardial contours at end-systole (2.) 
and onto the result of the strain analysis, represented by a 
color-coded map of the heart (3.). GCS was quantified in 
the three long-axis images by drawing epi- and endocardial 
contours manually at end-systole (as seen in Fig. 2), iden-
tified by the size of the heart and the color-coding of the 
images signaling contraction (blue). Papillary muscles and 
trabeculae were excluded from the endocardial contour. GLS 
was quantified using the short-axis images, again by drawing 
epi- and endocardial contours at end-systole (Fig. 2). The LV 
was automatically divided into 16 segments in the short-axis 
views and 21 segments in the long-axis views (according to 
the AHA model [21]) and segmental strain was calculated 
by applying an automated tracking algorithm. Peak systolic 
GCS and GLS were calculated as the average strain of all 
segments at end-systole in the long- and short-axis views, 
respectively. Scans were only excluded from the analysis if 
Fig. 2  fSENC- and corresponding color-coded images after post-pro-
cessing at end-systole (blue representing strain in the normal range 
during contraction), as well as the myocardial segmentation as illus-
trated by the software. Legend: 1. = Images as shown on the scanner, 
2. = Color-coded images on the software after post-processing, dis-
playing manually drawn epi-and endocardial contours at end-systole, 
3. = Results of the strain analysis, represented by a color-coded map 
of the heart
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no view could be analyzed due to insufficient image quality 
(e.g. GCS could not be determined due to insufficient image 
quality of the 2-,3- and 4-chamber images). Figure 3 shows 
exemplary images of the same volunteer at the three sites, as 
displayed on the scanner and after post-processing. 
Intra‑ and inter‑observer reproducibility analysis
Measurements were repeated in a subset of three random 
volunteers per site (9 volunteers = 36 scans) by the first 
observer two months after the first analysis and by a sec-
ond observer who received the same training by software 
representatives beforehand, blinded to all previous strain 
measurements. Before repeating the analysis, both observ-
ers came to a consensus of excluding volunteers, if both 
observers considered no view to have the sufficient image 
quality to determine either GCS or GLS reliably.
Statistical analysis
The distribution of all values was assessed for normality 
using the Shapiro-Wilks test. Normally distributed data 
is expressed as mean ± standard deviation, non-normally 
distributed data using median and interquartile range 
(IQR). Inter-vendor agreement between the three sites was 
determined using Bland-Altman analysis. Test-retest repro-
ducibility between averaged scans before (average strain of 
scan 1 and 2) and after the fifteen-minute break (average 
strain of scan 3 and 4) and between single scans was deter-
mined using intraclass correlation (ICC) and coefficients 
of variation (CoV). Wilcoxon test (for non-normally dis-
tributed strain parameters) and paired students t-test (for 
normally distributed strain parameters) were calculated to 
determine if differences in strain values between the sites 
and before and after the break were significant. Intra- and 
inter-observer reproducibility were analyzed using ICC 
and CoV. The following levels of agreement were used: 
excellent for ICC > 0.74, good for ICC 0.6–0.74, fair for 
ICC 0.4–0.59 and poor for ICC < 0.4 [2, 22]. All values are 
expressed using p-values and confidence intervals. A p-value 
of ≤ 0.05 was considered significant in two-tailed tests. Sta-
tistical analyses were conducted using SPSS (Version 25.0, 
IBM Corp., Armonk, NY, USA).
Results
fSENC-image acquisitions of the gel-phantoms were 
repeated several times. Mean strain and standard deviation 
were − 28.1% (± 0.3) for the system used at site I, − 23.7 
Fig. 3  4-chamber view images of the same volunteer scanned at the three different sites, as shown on the scanner and after post-processing
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(± 0.9) for the system used at site II and − 26.8 (± 1.4) for 
the system used at site III. Table 1 portrays the baseline char-
acteristics of the volunteers, vital signs and median (IQR) 
strain values. One complete fSENC-examination includ-
ing all images was acquired in a median (IQR) scan time 
of two (1–4) min at all sites. Median image analysis time 
ranged from 10 to 14 min for one whole examination. A 
total of four scans were performed for each volunteer (twice 
before and twice after the break). At site I, one scan had to 
be excluded from GLS-analysis owing to motion artifacts 
during acquisition of the short-axis images. At site II, one 
volunteer could not be scanned due to unexpected technical 
difficulties. Further four scans were excluded from GLS- and 
nine from GCS-analysis because of artifacts that would not 
allow reliable contouring of the heart. At site III, no scan 
was excluded. A total of 51 scans (85.0%) were left for GLS-
and 47 scans (78.3%) for GCS-analysis.
Inter‑vendor agreement
Figure 4 shows box and whisker-plots to illustrate the 
range of strain values with regard to the different sites and 
the significance level of the differences, as calculated from 
the Bland-Altman analysis. The range of GLS-measure-
ments was wider than of GCS-measurements. Differences 
in strain values were significant when comparing site I 
against either site II or III. Table 2 and Fig. 5 display the 
results of the Bland-Altman analysis. Inter-vendor agree-
ment was good between all sites, shown by small biases 
(0.01–1.88% strain), but the limits of agreement (LOA) 
reflected a possible inconsistency regarding individual 
patients. Biases and limits of agreement were significant 
when comparing site I against either site II or III.  
Table 1  Baseline characteristics of the volunteers (n = 15), median (IQR) scan time and median strain values (IQR) at the different sites
Volunteer characteristics Site I Site II Site III
Female, n (%) 8 (53%) 8 (53%) 8 (53%)
Age (years) 25 (± 5) 25 (± 5) 25 (± 5)
Height (cm) 174 (± 9) 173 (± 8) 174 (± 9)
Weight (kg) 66 (± 11) 66 (± 11) 66 (± 11)
Smoking, n (%) 2 (13%) 3 (20%) 3 (20%)
Blood pressure before exam (mmHg) 123 (± 18)/68(± 11) 129 (± 18)/74 (± 9) 123 (± 16)/64 (± 9)
Blood pressure after exam (mmHg) 112 (± 17)/61(± 7) 127 (± 15)/70(± 7) 120 (± 16)/62(± 10)
Heart rate before exam (bpm) 74(± 12) 77 (± 15) 67 (± 12)
Heart rate after exam (bpm) 69(± 7) 75 (± 11) 76 (± 9)
Scan time (min.) 2 (1–2) 3 (2–6) 3 (1–4)
LV-GLS (%) (n = 51) − 19.2 (− 20.5 to − 18.0) − 17.8 (− 20.0 to − 16.4) − 17.9 (− 20.0 to − 16.0)
LV-GCS (%) (n = 47) − 19.7 (− 21.1 to − 18.3) − 18.9 (− 20.0 to − 17.1) − 18.2 (− 19.2 to − 16.8)
Fig. 4  Box and whisker-plots to illustrate the range of strain values with regard to the different sites and the significance level of the differences
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Test‑retest reproducibility
Table 3 displays the median (IQR) strain values of the 
averaged scans before and after the break and the corre-
sponding p-value, as well as the ICC (95% CI) and CoV 
(± sd). As shown by the good- to excellent ICC- and CoV-
values, test-retest reproducibility of averaged scans before 
and after the break was very high for all sites. The high-
est test-retest reproducibility was observed for LV-GLS 
at site II (ICC = 0.97) and the lowest for LV-GLS at site I 
(ICC = 0.63). At site I, test-retest reproducibility was higher 
for GCS-measures, whereas at site II and III, it was higher 
for GLS-measures. Nevertheless, differences in median 
strain between scans before and after the break were mostly 
insignificant (except for LV-GLS for site I). Table 4 shows 
the scan-rescan reproducibility between single scans. Over-
all, scan-rescan reproducibility was good, independent of 
Table 2  Results of the Bland-Altman analysis illustrating inter-ven-
dor agreement
Bias (%) LOA (%) p
LV-GLS (n = 51)
 Site I vs. II 1.21 − 5.25 to 7.68 0.012
 Site I vs. III 1.24 − 4.47 to 6.92 0.004
 Site II vs. III 0.01 − 4.78 to 4.81 0.968
LV-GCS (n = 47)
 Site I vs. II 1.14 − 2.34 to 4.64 < 0.001
 Site I vs. III 1.88 − 3.02 to 6.79 < 0.001
 Site II vs. III 0.61 − 3.99 to 5.20 0.083
Fig. 5  Bland-Altman analysis comparing GLS and GCS between the different sites. Legend: a Site I vs. II, b Site I vs. III, c Site II vs. III
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scanner site (ICC = 0.97–0.70). The highest scan-rescan 
repeatability could be observed for site II between scans 3 
and 4 and 1 and 3, the lowest regarding site I between scans 
1 and 3. 
Intra‑ and inter‑observer reproducibility
Both observers independently excluded one volunteer out 
of nine from strain analysis, resulting in 32 scans. Intra- 
and inter-observer reproducibility were very high overall 
(Table 5), but even higher for GLS than for GCS.
Discussion
It has been shown that strain, determined using either echo-
cardiography or CMR, is a valuable parameter to determine 
the impact of coronary artery disease on heart function 
[12], to detect LV dysfunction, especially in patients with 
heart failure when EF is still preserved [1, 4, 12, 23] and to 
reveal diffuse damage to the myocardium due to systemic 
diseases, such as cardiac amyloidosis [24, 25], sarcoidosis 
[26] or cardiotoxic effects of chemotherapy [5]. Despite 
these many possible indications, the use of strain in clinical 
routine is still challenging due to the impact of intra-, inter-
observer- [7] and inter-vendor reproducibility of the differ-
ent post-processing platforms [8, 9, 27] on strain results, 
which could also explain the lack of inter-technique agree-
ment between echocardiography and CMR [28]. Therefore, 
before conducting studies to validate strain techniques in 
large patient cohorts, it is important to (1) identify the possi-
ble factors influencing strain results and to (2) minimize the 
impact of these factors. To address this issue, we compared 
GLS and GCS in healthy volunteers, who were all scanned 
using fSENC at three different sites with MRI scanners from 
major vendors.
Our results show:
(1) good inter-vendor agreement of strain measurements 
using fSENC between all three vendors overall, 
reflected by small biases but substantial limits of agree-
ment
(2) very good test-retest reproducibility of fSENC when 
scanning volunteers again after a fifteen-minute break, 
regardless of vendor, and
(3) good to excellent intra- and inter-observer reproduc-
ibility of fSENC strain measurements.
To our knowledge, no previous data on inter-vendor 
agreement of a CMR-technique to determine strain exists. 
Nevertheless, the influence of different ultrasound systems 
on 2D- and 3D-STE has been reported previously [7, 29–31]. 
As in our study, differences in STE-strain measurements 
between the different vendors were significant [7, 29, 30]. 
However, the bias between different ultrasound systems was 
similar or higher (0.1–3.7 [7], 1.1–7.0 [30], 1–1.55% [31]) 
than the bias between magnetic resonance scanners deter-
mined in our study group of fifteen volunteers (0.01–1.88%), 
with limits of agreement of a similar magnitude. The bias 
in our cohort of healthy volunteers was significant between 
site I and II or III. Moreover, the limits of agreement indi-
cate that in some individuals the difference in strain values 
could be considerably higher than the bias. We believe that 
this study demonstrates the importance of further exploring 
inter-vendor agreement in larger cohorts to validate these 
results and to determine the agreement related to different 
scanners in patients. Our results indicate that it might pos-
sibly be helpful to implement scanner-related normal values 
and that one should be aware of this possible bias and limits 
of agreement when comparing strain results acquired at dif-
ferent scanners. This should also play a role when designing 
classifications based on strain, which determine diagnostic 
procedures and therapeutic decisions for patients.
An important factor that could influence inter-vendor 
agreement is the difference in technical characteristics of 
Table 3  Median (IQR) strain 
before and after the 15-min 
break at every site and results 
of the ICC (95% CI) and CoV 
(± sd) to display test-retest 
reproducibility
Median (IQR) strain p ICC (95%CI) p CoV (± sd)
Site I LV-GLS − 20.1 (− 20.9 to − 18.3) 0.020 0.63 (0.21 to 0.86) 0.002 0.06 (± 0.05)
− 19.4 (− 20.6 to − 17.8)
LV-GCS − 19.0 (− 21.1 to − 18.3) 0.950 0.82 (0.53 to 0.93)  < 0.001 0.05 (± 0.03)
− 19.4 (− 21.0 to − 18.3)
Site II LV-GLS − 19.9 (− 21.3 to − 16.8) 0.347 0.97 (0.90 to 0.99)  < 0.001 0.03 (± 0.02)
− 20.1 (− 21.2 to − 17.0)
LV-GCS − 17.4 (− 19.0 to − 16.4) 0.307 0.80 (0.47 to 0.94)  < 0.001 0.04 (± 0.04)
− 17.3 (− 18.6 to − 16.7)
Site III LV-GLS − 18.8 (− 20.2 to − 15.1) 0.977 0.82 (0.54 to 0.94)  < 0.001 0.09 (± 0.07)
− 18.4 (− 19.8 to − 16.2)
LV-GCS − 17.2 (− 18.6 to − 16.3) 0.056 0.69 (0.29 to 0.88) 0.001 0.07 (± 0.05)
− 18.5 (− 19.5 to − 16.5)
907The International Journal of Cardiovascular Imaging (2020) 36:899–911 
1 3
the pulse sequence at the different scanners. A spiral read-
out was used at sites I and II, whereas an EPI was used 
at site III, which may have different properties in terms of 
geometric distortion and susceptibility to off-resonant spins. 
Furthermore, the pulse sequence varied with regard to most 
scanning parameters for each scanner. In order to determine 
the influence of the pulse sequence alone on strain meas-
urements, phantoms were scanned at sites with the three 
different scanning systems before scanning the volunteers. 
Mean strain values of the phantoms were higher using the 
scanning systems at site II and III than using the system 
at site I, similar to the pattern of median GLS and GCS of 
the volunteers. This suggests that the pulse sequence itself 
could contribute to differences in strain values. Other possi-
ble variables with impact on inter-vendor agreement are the 
planning and training of different technicians, the experience 
and training of the observers and changes in the physiology 
of the volunteers. In order to minimize the effect of dif-
ferences in knowledge and training of the technicians and 
observers in our study, all received training on image plan-
ning/analysis and completed written tests. Furthermore, a 
standardized imaging protocol was used at all three sites, but 
technicians were allowed to adjust the scanning parameters. 
Additionally, if two technicians performed the scanning, 
different levels of experience and planning styles resulted 
in different image planning at the same scanner. Due to the 
above listed reasons, the scans were of variable quality, 
which may have affected strain measurements. To monitor 
and reduce volunteer-related bias, volunteers were asked 
questions regarding their health, medications and smoking 
behavior before every scan and height, weight, blood pres-
sure and heart frequency were monitored. Volunteers with 
new onset of disease or new intake of medication would 
have been excluded, but the impact of changes in factors 
such as weight and smoking behavior on strain measure-
ments were not ruled out. In addition, it was not possible to 
keep the time difference between the scans at the three sites 
consistent, so we could not eliminate changes in myocar-
dial function associated with timing of the scans. However, 
previous literature studying temporal variability of  T1- and 
 T2 mapping in volunteers after approximately 90 days [32] 
Table 4  Scan-rescan reproducibility, represented using ICC (95% CI) 
and CoV
ICC (95%CI) p CoV (± sd)
Site I GLS
 Scan 1 vs. 2 0.94 (0.81 to 0.98) < 0.001 0.03 (0.02)
 Scan 2 vs. 3 0.75 (0.16 to 0.92) 0.002 0.07 (0.04)
 Scan 3 vs. 4 0.97 (0.91 to 0.99) < 0.001 0.02 (0.02)
 Scan 1 vs. 3 0.70 (0.15 to 0.90) 0.013 0.06 (0.06)
 Scan 1 vs. 4 0.74 (0.27 to 0.91) 0.007 0.06 (0.06)
 Scan 2 vs. 4 0.79 (0.33 to 0.93) 0.002 0.07 (0.05)
GCS
 Scan 1 vs. 2 0.89 (0.68 to 0.96) < 0.001 0.05 (0.06)
 Scan 2 vs. 3 0.83 (0.47 to 0.94) 0.002 0.07 (0.06)
 Scan 3 vs. 4 0.86 (0.56 to 0.95) 0.001 0.05 (0.04)
 Scan 1 vs. 3 0.79 (0.37 to 0.93) 0.004 0.06 (0.04)
 Scan 1 vs. 4 0.86 (0.58 to 0.95) < 0.001 0.05 (0.04)
 Scan 2 vs. 4 0.88 (0.62 to 0.96) < 0.001 0.06 (0.05)
Site II GLS
 Scan 1 vs. 2 0.88 (0.61 to 0.96) < 0.001 0.07 (0.07)
 Scan 2 vs. 3 0.94 (0.80 to 0.98) < 0.001 0.04 (0.05)
 Scan 3 vs. 4 0.97 (0.91 to 0.99) < 0.001 0.03 (0.03)
 Scan 1 vs. 3 0.97 (0.89 to 0.99) < 0.001 0.04 (0.03)
 Scan 1 vs. 4 0.94 (0.81 to 0.98) < 0.001 0.06 (0.04)
 Scan 2 vs. 4 0.95 (0.77 to 0.99) < 0.001 0.05 (0.04)
GCS
 Scan 1 vs. 2 0.94 (0.79 to 0.98) < 0.001 0.04 (0.04)
 Scan 2 vs. 3 0.89 (0.61 to 0.97) 0.001 0.05 (0.03)
 Scan 3 vs. 4 0.85 (0.52 to 0.96) 0.001 0.05 (0.04)
 Scan 1 vs. 3 0.79 (0.20 to 0.95) 0.013 0.06 (0.04)
 Scan 1 vs. 4 0.85 (0.46 to 0.96) 0.002 0.04 (0.06)
 Scan 2 vs. 4 0.85 (0.50 to 1.00) 0.002 0.05 (0.05)
Site III GLS
 Scan 1 vs. 2 0.92 (0.77 to 0.97) < 0.001 0.08 (0.09)
 Scan 2 vs. 3 0.84 (0.51 to 0.95) 0.001 0.10 (0.11)
 Scan 3 vs. 4 0.96 (0.90 to 0.99) < 0.001 0.06 (0.05)
 Scan 1 vs. 3 0.89 (0.67 to 0.96) < 0.001 0.09 (0.09)
 Scan 1 vs. 4 0.89 (0.68 to 0.97) < 0.001 0.10 (0.08)
 Scan 2 vs. 4 0.85 (0.55 to 0.95) 0.001 0.10 (0.08)
GCS
 Scan 1 vs. 2 0.90 (0.70 to 0.97) < 0.001 0.06 (0.03)
 Scan 2 vs. 3 0.71 (0.18 to 0.90) 0.012 0.08 (0.06)
 Scan 3 vs. 4 0.85 (0.56 to 0.95) 0.001 0.06 (0.05)
 Scan 1 vs. 3 0.71 (0.12 to 0.90) 0.005 0.08 (0.06)
 Scan 1 vs. 4 0.79 (0.38 to 0.93) < 0.001 0.08 (0.05)
 Scan 2 vs. 4 0.83 (0.50 to 0.94) 0.001 0.07 (0.05)
Table 5  Intra- and inter-observer reproducibility, reflected by ICC 
(95% CI) and CoV (± sd)
ICC (95%CI) p CoV (± sd)
Intra-observer reproduc-
ibility
 LV-GLS 0.99 
(0.98 to 1.00)
< 0.001 0.02 ± 0.02
 LV-GCS 0.77 
(0.47 to 0.90)
< 0.001 0.05 ± 0.04
Inter-observer reproduc-
ibility
 LV-GLS 0.96 
(0.92 to 0.98)
< 0.001 0.03 ± 0.04
 LV-GCS 0.82 
(0.58 to 0.92)
< 0.001 0.04 ± 0.03
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and 4D flow in 10 volunteers with a difference of one year 
between scans [33] reported no significant differences or 
significant agreement of results, indicating that myocardial 
function in healthy volunteers should be stable over a cer-
tain time period up to 1 year. Furthermore, the volunteers 
were also scanned at different time-points during the day, 
allowing for short-term differences in loading conditions to 
possibly affect strain results. Nevertheless, we only observed 
minor changes in volunteer characteristics, vital parameters 
and CMR-parameters, so we assume that myocardial func-
tion was stable in our group of volunteers during the course 
of the study.
The good to excellent test-retest reproducibility of aver-
aged scans before and after the break and between single 
scans observed in our group of volunteers, regardless of MRI 
scanner used, matches the excellent test-retest reproducibil-
ity Giusca et al. reported in fSENC scans of eleven healthy 
subjects and seven patients with heart failure repeated 
63 days apart [2]. These results also suggest that effects of 
short-term differences in myocardial function relating to 
loading conditions, stroke volume and heart frequency are 
minimal in volunteers. Furthermore, the very good to excel-
lent intra- and inter-observer reproducibility we reported 
agrees with previous studies investigating fSENC [2, 15] 
as well.
When comparing CMR techniques to measure strain, 
obstacles preventing broad clinical use are centered around 
the long acquisition and post-processing time, especially 
concerning myocardial tagging [15, 34]. Due to the fast 
image acquisition without the need for breath-holds, fSENC 
could be a potential alternative to tagging. Strain measure-
ments using fSENC have already been shown to be valuable 
to detect hypertrophic cardiomyopathy when EF is preserved 
[35], right-ventricular dysfunction due to pulmonary hyper-
tension [36] and diastolic dysfunction in patients with type II 
diabetes mellitus [37]. Furthermore, fSENC reliably identi-
fies myocardial regions affected by coronary artery disease 
and infarction [38] and reliably estimates LV-volumes and 
EF in patients with coronary artery disease, as shown by a 
recent study from our group [39].
Clinical implications
Our results suggest that an average bias of 0.01% to 1.88% 
strain (< 1.24% for GLS and < 1.88% for GCS) should 
be taken into account when comparing fSENC results of 
healthy individuals acquired using different scanners. This 
implies that a strain difference of below 2% on average may 
represent normal variability in the measurement and not 
necessarily a decrease or increase in myocardial function, if 
scanning is performed using different scanners. The limits of 
agreement indicate that strain results from different scanners 
should not be used totally interchangeably. Larger studies 
are needed for further validation in order to facilitate the 
planning and comparison of multi-center studies, which are 
needed for standardization of strain measurements and to 
determine inter-vendor agreement in patients. Furthermore, 
technical differences between different scanners and imaging 
sequences should be assessed.
Limitations
Our study group is composed of a relatively small sample 
size of healthy young volunteers, in order to eliminate the 
influence of pathologies on strain measurements. Hence, 
it is important to conduct further studies to assess inter-
vendor agreement in a larger study cohort and in patients. 
Furthermore, in-vitro scanning was performed using differ-
ent phantoms, at different sites than where the volunteers 
were scanned and with different number of repeats per site. 
Unfortunately, multiple scans at site II had to be excluded 
from further strain analysis due to technical complications 
that similarly occur in the clinical routine, such as a defect 
optical fiber cable (preventing one volunteer from being 
scanned) and a malfunctioning body coil, resulting in arti-
facts during four GLS and five GCS scans. Additionally, we 
only focused on fSENC in this study and did not include 
conventional tagging, the gold standard for strain measure-
ments, since fSENC had previously been validated against 
tagging [15]. Similarly, we did not evaluate other techniques 
for measuring strain. Nevertheless, it would be interesting 
to examine the impact of different MRI scanners on other 
CMR techniques used to determine strain, including tagging.
Conclusion
We found good inter-vendor agreement of strain measure-
ments acquired with the fSENC technique at 3 T using MRI 
scanners from three major vendors with small biases, but 
considerable limits of agreement and a significant difference 
in strain results. Test-retest reproducibility between repeated 
scans was very high, regardless of the scanner chosen. More-
over, reproducibility of strain measurements was good to 
excellent, independent of the employed MR-platform. 
fSENC can be considered a reliable technique and suitable 
for strain measurements at different centers and, with further 
development, has the potential to improve diagnostics and 
therapy in heart failure patients. Our results might help to 
interpret strain assessed by fSENC at different sites using 
MRI scanners from different vendors.
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